IRLAB Therapeutics AB Class A (IRLAB.A) Income Statement

Last quarter (Q4 2024), IRLAB Therapeutics AB Class A's total revenue was kr42.82M, a decrease of -3692.28% from the same quarter last year. In Q4, IRLAB Therapeutics AB Class A's net income was kr-5.39M. See IRLAB Therapeutics AB Class A’s key income statements, including revenue, expenses, profit, and income.